Vanda Pharmaceuticals Inc Net Asset Quality Index
Vanda Pharmaceuticals Inc net asset quality index. Vanda Pharmaceuticals Inc (VNDA) has a Net Asset Quality Index of 66.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $488.95 Million minus total liabilities of $161.76 Million yields net assets of $327.19 Million. A higher index indicates a stronger, lower-leverage balance sheet. See VNDA net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Vanda Pharmaceuticals Inc (2004–2025)
Net asset quality index of Vanda Pharmaceuticals Inc from 2004 to 2025. This chart shows how Vanda Pharmaceuticals Inc's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the index stands at 66.9%, representing net assets of $327.19 Million against total assets of $488.95 Million USD. Check Vanda Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Vanda Pharmaceuticals Inc Net Asset Quality Index by Year (2004–2025)
Vanda Pharmaceuticals Inc net asset quality index by year from 2004 to 2025. The table below presents the year-by-year Net Asset Quality Index for Vanda Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see VNDA market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.9% | $327.19 Million | $488.95 Million | $161.76 Million | ▼ -15.2 pp |
| 2024 | 82.1% | $538.55 Million | $656.20 Million | $117.66 Million | ▼ -2.0 pp |
| 2023 | 84.0% | $544.91 Million | $648.44 Million | $103.53 Million | ▲ +0.9 pp |
| 2022 | 83.1% | $527.20 Million | $634.25 Million | $107.05 Million | ▼ -1.9 pp |
| 2021 | 85.0% | $504.93 Million | $593.79 Million | $88.86 Million | ▲ +0.1 pp |
| 2020 | 85.0% | $453.27 Million | $533.46 Million | $80.19 Million | ▲ +0.0 pp |
| 2019 | 85.0% | $410.94 Million | $483.75 Million | $72.80 Million | ▲ +2.0 pp |
| 2018 | 82.9% | $275.42 Million | $332.13 Million | $56.71 Million | ▲ +19.0 pp |
| 2017 | 64.0% | $131.39 Million | $205.43 Million | $74.04 Million | ▲ +1.5 pp |
| 2016 | 62.4% | $131.33 Million | $210.37 Million | $79.04 Million | ▼ 0.0 pp |
| 2015 | 62.4% | $133.03 Million | $213.05 Million | $80.02 Million | ▼ -31.2 pp |
| 2014 | 93.7% | $160.82 Million | $171.70 Million | $10.89 Million | ▲ +62.9 pp |
| 2013 | 30.8% | $44.12 Million | $143.35 Million | $99.22 Million | ▲ +23.5 pp |
| 2012 | 7.3% | $9.90 Million | $135.45 Million | $125.54 Million | ▼ -11.0 pp |
| 2011 | 18.3% | $33.47 Million | $182.62 Million | $149.14 Million | ▲ +0.6 pp |
| 2010 | 17.7% | $37.73 Million | $213.10 Million | $175.37 Million | ▲ +7.5 pp |
| 2009 | 10.2% | $23.03 Million | $225.71 Million | $202.68 Million | ▼ -82.0 pp |
| 2008 | 92.2% | $46.02 Million | $49.93 Million | $3.91 Million | ▲ +5.7 pp |
| 2007 | 86.4% | $83.73 Million | $96.86 Million | $13.13 Million | ▲ +12.7 pp |
| 2006 | 73.8% | $26.76 Million | $36.26 Million | $9.50 Million | ▼ -12.0 pp |
| 2005 | 85.8% | $30.66 Million | $35.75 Million | $5.09 Million | ▼ -4.0 pp |
| 2004 | 89.8% | $15.94 Million | $17.75 Million | $1.81 Million | — |